Authors: Millan, MJ Gobert, A Newman-Tancredi, A Lejeune, F Cussac, D Rivet, JM Audinot, V Adhumeau, A Brocco, M Nicolas, JP Boutin, JA Despaux, N Peglion, JL

Citation: Mj. Millan et al., S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile, J PHARM EXP, 292(1), 2000, pp. 38-53

Authors: Millan, MJ Brocco, M Rivet, JM Audinot, V Newman-Tancredi, A Maiofiss, L Queriaux, S Despaux, N Peglion, JL Dekeyne, A

Citation: Mj. Millan et al., S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents, J PHARM EXP, 292(1), 2000, pp. 54-66